Together, these results indicate that the serum from FSHD-like chronic mice was enriched with chemokines and cytokines, particularly eotaxin at early stages, CXCL1 at early and mid-stages, and CXCL9 at mid and late stages of disease progression. Here, CCL11 is linked to facioscapulohumeral muscular dystrophy.